The failure of the Eyenovia CHAPERONE study has seen the company’s stock value drop drastically as it weighs up options and ...

Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership with ALZpath, Inc to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer's ...

Alnylam Pharmaceuticals has revealed new interim data from its Phase I trial of nucresiran, a ribonucleic acid interference (RNAi) therapeutic for transthyretin (ATTR) amyloidosis treatment. The study ...

Dr Athman says that among the people with cancer in Kenya, prostate cancer lies third, in terms of the number of patients.

On a sunny day in July, while other Bay Area kids were playing at camps or water parks, 8-year-old Charlotte O’Neill was leaning back in a reclining chair in a small, carpeted San Jose office room.

UK health officials say the increase is largely due to an uptick in antibiotic-resistant Escherichia coli infections.

AC Immune’s Phase II trial showed an increase in anti-a-syn antibodies following treatment with the Parkinson’s disease ...

de Filippis, R. and Al Foysal, A. (2024) Case Report: The Role of Monoamine Oxidase Inhibitors in Treating Resistant Depression. Open Access Library Journal, 11, 1-12. doi: 10.4236/oalib.1112369 .

Read the Market Summary Here @- Brazil Diagnostic Labs Market Size Booming at CAGR of More Than 9% to Touch USD 13.65 Billion & Volume of 22,173 Units by 2030 Brazil Diagnostic Labs Market is ...

A cause of death for music legend Quincy Jones has been announced. According to a death certificate obtained by various ...

As a result, auto features are providing opportunities for "midlife consumption" rather than long-term wealth accumulation, ...

The company plans to discontinue the study after the combination therapy failed to meet the primary endpoint in the Phase III ...